Margaret K. Callahan

Also affiliated with UConn Health

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Data from First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Figshare(2023)10.1158/1078-0432.22487576.v1

Top 100%

0DataRank

Top 100%0 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

Papers

Driven by 29 papers — median percentile 0. Top paper: “Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab”.

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

JAMA Oncology(2020)10.1001/jamaoncol.2019.6152

N/A

5.0DataRank · unranked

207 citations

Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson +21 more

Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child

Nature Medicine(2021)10.1038/s41591-021-01388-5

N/A

2.7DataRank · unranked

113 citations

Rui Yang, Caner Aytekin, David Langlais, Mathieu Bourgey, Taushif Khan +50 more

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

Nature Medicine(2024)10.1038/s41591-024-03040-4

N/A

2.1DataRank · unranked

107 citations

Minita Shah, Amanda Frydendahl, Daniel Halmos, Cole C. Khamnei, Nadia Øgaard +56 more

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005147

N/A

1.7DataRank · unranked

66 citations

Michael J. Pishvaian, Margaret K. Callahan, Amy Weise, Branimir I. Šikić, Osama E. Rahma +19 more

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine(2021)10.1038/s41591-021-01406-6

N/A

0.910DataRank · unranked

429 citations

Connie P. M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, W. S. Chen, Lisa Derosa +66 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Fundamental immune–oncogenicity trade-offs define driver mutation fitness

Nature(2022)10.1038/s41586-022-04696-z

N/A

0.663DataRank · unranked

82 citations

Roberta Zappasodi, Isabell Schulze, Zachary Sethna, Kelvin C. de Andrade, Dean F. Bajorin +25 more

A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3936

N/A

0.571DataRank · unranked

44 citations

Susan J. Knox, Debra A. Goldman, Yuval Elhanati, Vikram Mavinkurve, Phillip Wong +20 more

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors

The Oncologist(2025)10.1093/oncolo/oyaf017

N/A

0.473DataRank · unranked

11 citations

Yonina R. Murciano‐Goroff, Antoine Desîlets, Guilherme Harada, Michael A. Postow, Margaret K. Callahan +9 more

Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-1083

N/A

0.453DataRank · unranked

6 citations

Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete +27 more

Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.17.476508

N/A

0.434DataRank · unranked

17 citations

Minita Shah, Nadia Øgaard, Cole C. Khamnei, Amanda Frydendahl, Aditya Deshpande +37 more

Response to “Ipilimumab (Yervoy) and the TGN1412 catastrophe”

Immunobiology(2012)10.1016/j.imbio.2011.11.001

N/A

0.416DataRank · unranked

15 citations

Margaret K. Callahan, Sumit K. Subudhi, James P. Allison, Michael A. Curran

Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.17.516904

N/A

0.345DataRank · unranked

9 citations

Adam J. Widman, Anushri Arora, Itai Rusinek, William F. Hooper, Rebecca L. Murray +30 more

A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100546

N/A

0.292DataRank · unranked

6 citations

Jasme Lee, Matthew Adamow, Colleen Maher, Michael A. Postow, Margaret K. Callahan +3 more

Scalable topic modelling decodes spatial tissue architecture for large-scale multiplexed imaging analysis

Nature Communications(2025)10.1038/s41467-025-61821-y

N/A

0.257DataRank · unranked

4 citations

James W. Smithy, Mohammad Yosofvand, Caroline E. Kostrzewa, MaryLena Bleile, Fiona Ehrich +6 more

Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2574

N/A

0.241DataRank · unranked

4 citations

Christopher A. Desjardins, Paul A. Giardina, Kankana Bardhan, Swarna Pandian, Keith Halley +14 more

Paired plus-minus sequencing is an ultra-high throughput and accurate method for dual strand sequencing of DNA molecules

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.11.669689

N/A

0.210DataRank · unranked

3 citations

Itai Rusinek, Aaron Sossin, Adam J. Widman, Eti Meiri, Gat Krieger +32 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0.165DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9536

N/A

0.115DataRank · unranked

1 citations

Mark Klang, Michael A. Postow, Alexander N. Shoushtari, Ryan J. Sullivan, Jedd D. Wolchok +4 more

Cooperative Communication with Humans Evolved to Emerge Early in Domestic Dogs

Current Biology(2021)10.1016/j.cub.2021.06.051

N/A

0DataRank · unranked

57 citations

Kyle C. M. Smith, Megan Callahan-Beckel, Margaret K. Callahan, Kerinne Levy, Brenda S. Kennedy +10 more

Supplementary Data from First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Figshare(2023)10.1158/1078-0432.22487576.v1

Top 100%

0DataRank

Top 100%0 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

Cooperative Communication with Humans Evolved to Emerge Early in Dogs

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.12.425620

N/A

0DataRank · unranked

4 citations

Kyle C. M. Smith, Megan Callahan-Beckel, Margaret K. Callahan, Kerinne Levy, Brenda S. Kennedy +9 more

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3135

N/A

0DataRank · unranked

0 citations

Yonina R. Murciano‐Goroff, Justin Jee, Maria E. Arcila, Darren J. Buonocore, Jianjiong Gao +15 more

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4256

N/A

0DataRank · unranked

98 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

(2023)10.1158/2326-6066.c.6550763

N/A

0DataRank · unranked

0 citations

Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete +27 more

Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

(2023)10.1158/2326-6066.c.6550763.v1

N/A

0DataRank · unranked

0 citations

Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete +27 more

Uncovering the hidden structure of dynamic T cell composition in peripheral blood during cancer immunotherapy: a topic modeling approach

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.24.538095

N/A

0DataRank · unranked

0 citations

Jasme Lee, Matthew Adamow, Colleen Maher, Michael A. Postow, Margaret K. Callahan +3 more

Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4189

N/A

0DataRank · unranked

54 citations

Walid K. Chatila, Arshi Arora, Francisco Sánchez-Vega, Havish S. Kantheti, Jorge A. Rojas Zamalloa +18 more

Margaret K. Callahan

Indexed papers

Top data-sharing exemplar

Papers